{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-037819","form_type":"8-K","ticker":"QCLS","cik":"0001321834","company_name":"Q/C TECHNOLOGIES, INC.","filed_at":"2024-09-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.585982+00:00","generated_at":"2026-05-31T02:20:27.237521+00:00","sec_items":["5.08"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"TNF Pharmaceuticals sets 2024 annual meeting for Nov 25; deadlines for proposals and nominations announced","bullets":["2024 annual meeting scheduled for November 25, 2024; record date October 18, 2024.","Stockholder proposals for inclusion in proxy under Rule 14a-8 must be received by October 3, 2024.","Nominations and other business outside Rule 14a-8 must be submitted by October 3, 2024.","Universal proxy rule notices for non-company nominees also due by October 3, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-037819","json":"https://secwatch.observer/filing/0001493152-24-037819.json","markdown":"https://secwatch.observer/filing/0001493152-24-037819.md","text":"https://secwatch.observer/filing/0001493152-24-037819.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224037819/0001493152-24-037819-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321834/000149315224037819/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:20:27.237521+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}